PODD Jan 2025 250.000 call
| Previous close | 5.30 |
| Open | 7.50 |
| Bid | 7.70 |
| Ask | 8.80 |
| Strike | 250.00 |
| Expiry date | 2025-01-17 |
| Day's range | 5.30 - 7.50 |
| Contract range | N/A |
| Volume | |
| Open interest | 2 |
ZacksHere's What Key Metrics Tell Us About Insulet (PODD) Q1 Earnings
While the top- and bottom-line numbers for Insulet (PODD) give a sense of how the business performed in the quarter ended March 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Business WireInsulet Reports First Quarter 2024 Revenue Increase of 23% Year-Over-Year
ACTON, Mass., May 09, 2024--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced financial results for the three months ended March 31, 2024.
Business WireInsulet’s 2023 Sustainability Report Highlights Commitment to Product Accessibility and Responsible Growth
ACTON, Mass., May 07, 2024--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today released its 2023 Sustainability Report, which describes key accomplishments in environmental, social, and governance (ESG) areas in 2023. The report outlines how the Company’s efforts to focus on sustainability through product accessibility and responsible growth have generated value for our stakeholders.
